Cargando…
Active vitamin D supplementation and COVID-19 infections: review
SARS-CoV-2, causing the lethal disease COVid-19, is a public health emergency in the 2020 global pandemic. The outbreak and fast spreading of SARS-CoV-2 have a high morbidity and mortality specifically in elder patients with chronic diseases such as diabetes mellitus, arterial hypertension, chronic...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7787599/ https://www.ncbi.nlm.nih.gov/pubmed/33409846 http://dx.doi.org/10.1007/s11845-020-02452-8 |
_version_ | 1783632854603792384 |
---|---|
author | Farid, Nakhoul Rola, Nakhoul Koch, Elias A. T. Nakhoul, Nakhoul |
author_facet | Farid, Nakhoul Rola, Nakhoul Koch, Elias A. T. Nakhoul, Nakhoul |
author_sort | Farid, Nakhoul |
collection | PubMed |
description | SARS-CoV-2, causing the lethal disease COVid-19, is a public health emergency in the 2020 global pandemic. The outbreak and fast spreading of SARS-CoV-2 have a high morbidity and mortality specifically in elder patients with chronic diseases such as diabetes mellitus, arterial hypertension, chronic kidney disease, and organ transplanted patients with immunosuppressive therapy. Preliminary results support different treatments such as chloroquine and convalescent plasma infusion in severe cases, with good outcome. On the other hand, the efficacy of supplementation with active vitamin D, an immunomodulator hormone with antiinflammatory and antimicrobial effects, is unproven. A recent study reported that vitamin D attains antiviral effects, via blocking viral replication directly. SARS-CoV-2 primarily uses the immune evasion process during infection via the envelope spike glycoprotein, which is followed by a cytokine storm, causing severe acute respiratory disease syndrome and death. SARS-CoV-2, by using the well-known angiotensin-converting enzyme 2 by the protein spike, as the host receptor to enter into alveolar, myocardial, and renal epithelial cells, can be disrupted by vitamin D. However, the correlation between vitamin D levels and COVID-19 deaths in previous studies was insignificant. Retrospective studies demonstrated a correlation between vitamin D status and COVID-19 severity and mortality, while other studies did not find this correlation. Studies have shown that, vitamin D reduces the risk of acute viral respiratory tract infections and pneumonia via direct inhibition of viral replication, antiinflammatory and immunomodulatory effects. The data available today regarding the beneficial protective effect of vitamin D is unclear and with conflicting results. Large randomized control trials are necessary to test this hypothesis. In this review, we will explain the cross talk between the active vitamin D and the angiotensin-converting enzyme 2, and summarize the data from the literature. |
format | Online Article Text |
id | pubmed-7787599 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-77875992021-01-07 Active vitamin D supplementation and COVID-19 infections: review Farid, Nakhoul Rola, Nakhoul Koch, Elias A. T. Nakhoul, Nakhoul Ir J Med Sci Review Article SARS-CoV-2, causing the lethal disease COVid-19, is a public health emergency in the 2020 global pandemic. The outbreak and fast spreading of SARS-CoV-2 have a high morbidity and mortality specifically in elder patients with chronic diseases such as diabetes mellitus, arterial hypertension, chronic kidney disease, and organ transplanted patients with immunosuppressive therapy. Preliminary results support different treatments such as chloroquine and convalescent plasma infusion in severe cases, with good outcome. On the other hand, the efficacy of supplementation with active vitamin D, an immunomodulator hormone with antiinflammatory and antimicrobial effects, is unproven. A recent study reported that vitamin D attains antiviral effects, via blocking viral replication directly. SARS-CoV-2 primarily uses the immune evasion process during infection via the envelope spike glycoprotein, which is followed by a cytokine storm, causing severe acute respiratory disease syndrome and death. SARS-CoV-2, by using the well-known angiotensin-converting enzyme 2 by the protein spike, as the host receptor to enter into alveolar, myocardial, and renal epithelial cells, can be disrupted by vitamin D. However, the correlation between vitamin D levels and COVID-19 deaths in previous studies was insignificant. Retrospective studies demonstrated a correlation between vitamin D status and COVID-19 severity and mortality, while other studies did not find this correlation. Studies have shown that, vitamin D reduces the risk of acute viral respiratory tract infections and pneumonia via direct inhibition of viral replication, antiinflammatory and immunomodulatory effects. The data available today regarding the beneficial protective effect of vitamin D is unclear and with conflicting results. Large randomized control trials are necessary to test this hypothesis. In this review, we will explain the cross talk between the active vitamin D and the angiotensin-converting enzyme 2, and summarize the data from the literature. Springer International Publishing 2021-01-06 2021 /pmc/articles/PMC7787599/ /pubmed/33409846 http://dx.doi.org/10.1007/s11845-020-02452-8 Text en © Royal Academy of Medicine in Ireland 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Review Article Farid, Nakhoul Rola, Nakhoul Koch, Elias A. T. Nakhoul, Nakhoul Active vitamin D supplementation and COVID-19 infections: review |
title | Active vitamin D supplementation and COVID-19 infections: review |
title_full | Active vitamin D supplementation and COVID-19 infections: review |
title_fullStr | Active vitamin D supplementation and COVID-19 infections: review |
title_full_unstemmed | Active vitamin D supplementation and COVID-19 infections: review |
title_short | Active vitamin D supplementation and COVID-19 infections: review |
title_sort | active vitamin d supplementation and covid-19 infections: review |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7787599/ https://www.ncbi.nlm.nih.gov/pubmed/33409846 http://dx.doi.org/10.1007/s11845-020-02452-8 |
work_keys_str_mv | AT faridnakhoul activevitamindsupplementationandcovid19infectionsreview AT rolanakhoul activevitamindsupplementationandcovid19infectionsreview AT kocheliasat activevitamindsupplementationandcovid19infectionsreview AT nakhoulnakhoul activevitamindsupplementationandcovid19infectionsreview |